Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Frontiers in immunology(2023)
摘要
Mortality in HSCT recipients who develop COVID-19 is high and largely dependent on age, comorbidities, active hematologic disease, timing from transplant and severity of the infection.
更多查看译文
关键词
COVID-19 infection,SARS-CoV-2,allogeneic HSCT,hematological malignances,immunocompromised patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要